未登录

N

Nicoletta Ferrari

University of Genoa

H指数:38

被引数:4,697

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retinoic acid receptor γ1 (RARγ1) levels control RARβ2 expression in SK-N-BE2(c) neuroblastoma cells and regulate a differentiation-apoptosis switch

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2833

OAAI

Aspartate β-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3β crosstalk

IF2.9

2020-06-1113

OAAI

Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy

糖基化PTGS2在结直肠癌NSAIDS辅助治疗中的应用评价

IF5.2

2020-03-1115

OAAI

Human Gut-Associated Natural Killer Cells in Health and Disease

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-05-03108

OAAI

Prostaglandin-endoperoxide synthase 2 (cyclooxygenase-2), a complex target for colorectal cancer prevention and therapy

TRANSLATIONAL RESEARCH

IF5.9

2018-06-0137

PREAI

Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells

特异性ADAM10抑制剂位于霍奇金淋巴瘤和基质细胞释放的外泌体样囊泡中，并阻止向旁观者细胞携带的脱落酶活性

IF6.3

2018-01-1936

OAAI

Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer

CELL COMMUNICATION AND SIGNALING

IF8.9

2017-12-0828

OAAI

The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer

IF10.1

2017-08-0133

PREAI

Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity

IF6.3

2017-01-0646

OAAI

Expression of nuclear matrix proteins binding matrix attachment regions in prostate cancer. PARP-1: New player in tumor progression

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2015-04-0614

OA

Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression

IF10.1

2014-10-0194

PREAI

Glycogen Synthase Kinase 3 Regulates Cell Death and Survival Signaling in Tumor Cells under Redox Stress

IF7.7

2014-09-0119

OAAI

The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2013-05-01146

OAAI

Celecoxib induces proliferation and Amphiregulin production in colon subepithelial myofibroblasts, activating erk1-2 signaling in synergy with EGFR

IF10.1

2013-01-0120

PRE

Bronchoprotection in conscious guinea pigs by budesonide and the NO-donating analogue, TPI 1020, alone and combined with tiotropium or formoterol

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2012-09-059

OA

Xanthohumol Impairs Human Prostate Cancer Cell Growth and Invasion and Diminishes the Incidence and Progression of Advanced Tumors in TRAMP Mice

MOLECULAR MEDICINE

IF6.4

2012-08-2961

OAAI

The AKT/NF-κB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration

BIOCHEMICAL PHARMACOLOGY

IF5.6

2012-06-0157

PREAI

Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2011-10-2058

OAAI

Angioprevention with fenretinide: Targeting angiogenesis in prevention and therapeutic strategies

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IF5.6

2010-07-0146

PREAI

The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3β pathway and β-catenin stability

MOLECULAR CANCER

IF33.9

2010-06-1046

OAAI